Free Trial

Crescent Capital BDC (CCAP) Competitors

Crescent Capital BDC logo
$15.13 -0.11 (-0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$15.15 +0.02 (+0.13%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CCAP vs. MFIC, BCSF, GSBD, AOD, AGD, AWP, THQ, THW, AVK, and AFB

Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include MidCap Financial Investment (MFIC), Bain Capital Specialty Finance (BCSF), Goldman Sachs BDC (GSBD), Aberdeen Total Dynamic Dividend Fund (AOD), Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn World Healthcare Fund (THW), Advent Convertible and Income Fund (AVK), and AllianceBernstein National Municipal Income Fund (AFB). These companies are all part of the "financial services" industry.

Crescent Capital BDC vs. Its Competitors

Crescent Capital BDC (NASDAQ:CCAP) and MidCap Financial Investment (NASDAQ:MFIC) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 11.1%. MidCap Financial Investment pays an annual dividend of $1.52 per share and has a dividend yield of 11.8%. Crescent Capital BDC pays out 125.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 140.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years.

Crescent Capital BDC currently has a consensus target price of $17.25, suggesting a potential upside of 14.01%. MidCap Financial Investment has a consensus target price of $13.50, suggesting a potential upside of 4.90%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
MidCap Financial Investment
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are held by institutional investors. 1.1% of Crescent Capital BDC shares are held by insiders. Comparatively, 0.8% of MidCap Financial Investment shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Crescent Capital BDC has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, MidCap Financial Investment has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

In the previous week, MidCap Financial Investment had 4 more articles in the media than Crescent Capital BDC. MarketBeat recorded 16 mentions for MidCap Financial Investment and 12 mentions for Crescent Capital BDC. MidCap Financial Investment's average media sentiment score of 0.79 beat Crescent Capital BDC's score of 0.65 indicating that MidCap Financial Investment is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crescent Capital BDC
1 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MidCap Financial Investment
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MidCap Financial Investment has a net margin of 30.60% compared to Crescent Capital BDC's net margin of 24.12%. Crescent Capital BDC's return on equity of 10.55% beat MidCap Financial Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Crescent Capital BDC24.12% 10.55% 4.68%
MidCap Financial Investment 30.60%10.44%4.41%

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent Capital BDC$197.36MN/A$73.65M$1.3411.29
MidCap Financial Investment$301.78M3.98$98.82M$1.0811.92

Summary

Crescent Capital BDC beats MidCap Financial Investment on 10 of the 17 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCFIN IndustryFinance SectorNASDAQ Exchange
Market CapN/A$1.50B$12.45B$9.83B
Dividend Yield11.02%11.18%5.54%4.08%
P/E Ratio12.6110.3618.8223.75
Price / SalesN/A41.6225.79116.64
Price / Cash6.8411.2821.8559.05
Price / Book0.760.942.286.18
Net Income$73.65M$144.88M$1.00B$264.89M
7 Day Performance4.71%-0.41%1.22%2.66%
1 Month Performance3.77%-3.01%1.90%3.05%
1 Year Performance-16.04%-3.96%541.87%25.05%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCAP
Crescent Capital BDC
3.2883 of 5 stars
$15.13
-0.7%
$17.25
+14.0%
-14.5%$0.00$197.36M12.61N/ANews Coverage
Earnings Report
Dividend Announcement
MFIC
MidCap Financial Investment
1.5776 of 5 stars
$12.35
flat
$13.50
+9.3%
-2.3%$1.15B$301.78M9.96N/AEarnings Report
BCSF
Bain Capital Specialty Finance
2.3259 of 5 stars
$14.67
-0.4%
$16.50
+12.5%
-3.7%$954.86M$292.65M8.431,000
GSBD
Goldman Sachs BDC
1.2377 of 5 stars
$11.11
+0.6%
$12.00
+8.0%
-18.0%$1.29B$434.37M24.69N/ADividend Announcement
AOD
Aberdeen Total Dynamic Dividend Fund
N/A$8.89
+1.0%
N/A+4.6%$0.00$94.38M0.00N/ANegative News
Dividend Announcement
AGD
Abrdn Global Dynamic Dividend Fund
N/A$11.13
+0.7%
N/A+13.2%$0.00$25.50M0.00N/ADividend Announcement
AWP
abrdn Global Premier Properties Fund
N/A$3.84
+0.1%
N/A-5.7%$0.00$45.21M0.00N/ADividend Announcement
THQ
Abrdn Healthcare Opportunities Fund
N/A$16.25
+0.2%
N/A-22.9%$0.00$6.59M0.001,088Dividend Announcement
Short Interest ↓
High Trading Volume
THW
Abrdn World Healthcare Fund
N/A$10.91
+0.6%
N/A-14.7%$0.00$2.90M0.00N/ADividend Announcement
AVK
Advent Convertible and Income Fund
N/A$12.20
+0.2%
N/A-0.6%$0.00$51.89M0.00N/AShort Interest ↓
AFB
AllianceBernstein National Municipal Income Fund
N/A$10.25
+0.6%
N/A-11.0%$0.00$602.34K0.00N/APositive News
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:CCAP) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners